05-04-2020 Reginald (email: prestonrrp@yahoo.com) Вопрос: Gloomy tales http://fittor.top/wwwtub8com/ mrsnake July 24 - Merck & Co. on Wednesday said U.S.regulators had accepted its marketing application for the bloodclot drug vorapaxar, aimed at preventing heart attacks andstrokes in patients who have already had a heart attack but whohave no history of stroke.